Anti-munchies
A new weight loss drug that works by blocking a cannabinoid receptor in the brain has had “modest” success at helping people both lose weight and keep it off, researchers say. It also seemed to improve other risk factors for cardiovascular disease beyond what would be expected from weight loss alone.
But critics say the study’s methodology may have been flawed, given that almost half of its participants dropped out.
Hmmm, dropping out and cannabinoid receptors. Who would have thought?
0 Comments:
Post a Comment
<< Home